Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
News
2022
2021
Statement to EB148 on the COVID-19 response
2020
FACT SHEET: Impact and Knowledge of COVID-19 and related measures in rural Kenyan households
COVID-19 Technology Access Pool
Letter to Dr Tedros: The Challenge of Access to Insulin Amidst COVID-19
The fight against COVID-19: let’s make public investments count for people
2023
Response to European Consultation on Intellectual Property
IP in a Post-pandemic World
Annual Report 2022
Diagnostics to Address Antimicrobial Resistance
2022
Licensing and Access to Health Technologies
The TRIPS Agreement Laid Bare
HAI Statement to Intergovernmental Negotiating Body
Statement to WHA75 – Health Emergencies
Response to European Consultation on Compulsory Licensing
2021
Medicine Pricing and Access in Europe
Eudamed and CTIS: Lessons from EudraCT
Transparency and Medicines Policy in the EU
Statement to WHA74 on GSPOA
HAI Statement on The Oslo Medicines Initiative at the WHO Virtual Consultation with Non-State Actors, 31 March 2021
Response to EU’s HERA Initiative Consultation
Transparency, Accountability and Access to Medicines: European Projects 2021
Statement to EB148 on WHO reform: involvement of non-State actors in WHO’s governing bodies
Letter to Dr Tedros: Leadership and Advocacy for C-TAP
Statement to EB148 on global strategy and plan of action on public health, innovation and intellectual property
2020